person · Reporting owner
Trautwein Leonardo Mouta
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| USBC, Inc.KNWN · Entity 6370 | Chief Marketing Officer | March 15, 2023 | March 16, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
USBC, Inc.
Report date March 15, 2023 · Filed March 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,980 |
Reported balance
After 2023-03-15 transaction · row 1
1 source rowRow 1 · 2023-03-15 · Purchase · Acquired 6,000 · Balance 19,980 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.04 · Expires 2026-02-04 | Direct | 200,000 |
Reported balance
Holding disclosure · report date 2023-03-15 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 200,000 F1: Options vest quarterly over four years. No vesting during first 6 months. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.35 · Expires 2026-02-09 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2023-03-15 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 100,000 F2: Options vest upon FDA approval |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.09 · Expires 2026-12-16 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2023-03-15 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 100,000 F3: Options vest quarterly over four years. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.48 · Expires 2027-05-20 | Direct | 600,000 |
Reported balance
Holding disclosure · report date 2023-03-15 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 600,000 F3: Options vest quarterly over four years. |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest quarterly over four years. No vesting during first 6 months.
F2: Options vest upon FDA approval
F3: Options vest quarterly over four years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Mar 16, 2023 13:01 UTC | USBC, Inc. KNWN · Entity 6370 | PurchaseCommon Stock | 6,000 | $0.84 | $5,039.40 |
DisclosureSEC source: 0001161697-23-000163 · form4.xml · nonDerivative · entry 1 Trautwein Leonardo Mouta · CIK 0001931209 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,980 Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:29 UTC | USBC, Inc. KNWN · Entity 6370 | PurchaseCommon Stock | 10,000 | $1.65 | $16,500.00 |
DisclosureSEC source: 0001161697-22-000300 · form4.xml · nonDerivative · entry 1 Trautwein Leonardo Mouta · CIK 0001931209 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,980 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.